Connecting Fanconi's anaemia to breast cancer predisposition

Lancet

Volumn 360, Issue 9343, 2002, Pages 1344-1345

  Venkitaraman, Ashok R ^a,b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b HUTCHISON MRC RESEARCH CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; BRCA1 PROTEIN; BRCA2 PROTEIN; CHECKPOINT KINASE 2; DOUBLE STRANDED DNA; MITOMYCIN C; PROTEIN DERIVATIVE; PROTEIN FA A; PROTEIN FA B; PROTEIN FA C; PROTEIN FA D1; PROTEIN FA D2; PROTEIN FA E; PROTEIN FA F; PROTEIN FA G; UNCLASSIFIED DRUG;

ALLELE; AUTOSOMAL RECESSIVE DISORDER; BONE MARROW DEPRESSION; BREAST CARCINOGENESIS; BREAST CARCINOMA; CANCER INHIBITION; CANCER RISK; CELL DEATH; CHROMOSOME ABERRATION; CLINICAL FEATURE; COMPLEX FORMATION; DISEASE PREDISPOSITION; DNA CROSS LINKING; DNA DAMAGE; DNA RECOMBINATION; DNA REPAIR; DNA REPLICATION; DNA STRAND BREAKAGE; DRUG SENSITIVITY; FANCONI ANEMIA; GENE FUNCTION; GENE IDENTIFICATION; GENE INACTIVATION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GERM LINE; HEREDITY; HETEROZYGOTE; HOMOZYGOTE; HUMAN; IONIZING RADIATION; MOLECULAR MODEL; MYELOID LEUKEMIA; NOTE; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SISTER CHROMATID; SOMATIC MUTATION; SQUAMOUS CELL CARCINOMA;

EID: 0037010455     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(02)11414-0     Document Type: Note

References (11)

1. Joenje H., Patel K.J. The emerging genetic and molecular basis of Fanconi anaemia. Nat Rev Genet. 2:2001;446-457.
2. Nathanson K.N., Wooster R., Weber B.L. Breast cancer genetics: what we know and what we need. Nat Med. 7:2001;552-556.
3. Patel K.J., Yu V.P.C.C., Lee H., et al. Involvement of Brca2 in DNA repair. Mol Cell. 1:1998;347-357.
4. Xu X., Weaver Z., Linke S.P., et al. Centrosome amplification and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells. Mol Cell. 3:1999;389-395.
5. de Winter J.P., van der Weel L., de Groot J., et al. The Fanconi anemia protein FANCF forms a nuclear complex with FANCA, FANCC and FANCG. Hum Mol Genet. 9:2000;2665-2674.
6. Pace P., Johnson M., Tan W.M., et al. FANCE: the link between Fanconi anaemia complex assembly and activity. Embo J. 2:2002;3414-3423.
7. Garcia-Higuera I., Taniguchi T., Ganesan S., et al. Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. Mol Cell. 7:2001;249-262.
8. Howlett N.G., Taniguchi T., Olson S., et al. Biallelic inactivation of BRCA2 in Fanconi anemia. Science. 297:2002;606-609.
9. Venkitaraman A.R. Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell. 108:2002;171-182.
10. Lee J.S., Collins K.M., Brown A.L., Lee C.H., Chung J.H. hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response. Nature. 404:2000;201-204.
11. Taniguchi T., Garcia-Higuera I., Xu B., et al. Convergence of the fanconi anemia and ataxia telangiectasia signaling pathways. Cell. 109:2002;459-472.